Show simple item record

dc.contributor.authorGichangi, P
dc.contributor.authorDe Vuyst, H
dc.contributor.authorEstambale, Benson
dc.contributor.authorRogo Khama O.
dc.contributor.authorBwayo, JJ
dc.contributor.authorTemmerman, M
dc.date.accessioned2013-06-07T05:35:00Z
dc.date.available2013-06-07T05:35:00Z
dc.date.issued2002
dc.identifier.citationInt J Gynaecol Obstet. 2002 Jan;76(1):55-63.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/11818095
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29611
dc.description.abstractOBJECTIVES: To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. METHODS: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9-year period when national HIV prevalence went from 5% to 5-10%, to 10-15%. RESULTS: There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV-negative women. CONCLUSIONS: A two- to three-fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV-positive women who presented with cervical cancer were significantly younger than HIV-negative women.en
dc.language.isoenen
dc.titleHIV and cervical cancer in Kenyaen
dc.typeArticleen
local.publisherDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record